398 related articles for article (PubMed ID: 9693400)
1. The effects of progesterone and progestins on endometrial proliferation.
Moyer DL; Felix JC
Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
[TBL] [Abstract][Full Text] [Related]
2. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
[TBL] [Abstract][Full Text] [Related]
3. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the potency of orally administered progestins in women.
King RJ; Whitehead MI
Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
[TBL] [Abstract][Full Text] [Related]
6. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation.
Brooks PG; Serden SP; Davos I
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1601-6; discussion 1606-8. PubMed ID: 1904683
[TBL] [Abstract][Full Text] [Related]
7. Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy.
Whitehead MI; Townsend PT; Pryse-Davies J; Ryder T; Lane G; Siddle N; King RJ
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):791-5. PubMed ID: 6278933
[TBL] [Abstract][Full Text] [Related]
8. Micronized progesterone regulation of the endometrial glandular cycling pool.
Moyer DL; Felix JC; Kurman RJ; Cuffie CA
Int J Gynecol Pathol; 2001 Oct; 20(4):374-9. PubMed ID: 11603222
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
10. The morphologic response of the human endometrium to long-term treatment with progestational agents.
Ludwig H
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):796-808. PubMed ID: 7065058
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
12. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
15. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
16. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
17. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
19. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
[TBL] [Abstract][Full Text] [Related]
20. The endometrial nucleolar channel system as an indicator of progestin potency in HRT.
Ryder TA; Mobberley MA; Whitehead MI
Maturitas; 1995 Jun; 22(1):31-6. PubMed ID: 7666814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]